| 1Amphetamine |
|---|
| 2Amphetamine-d11 |
| 3Ephedrine |
| 4MDA |
| 5MDA-d5 |
| 6MDEA |
| 7MDEA-d5 |
| 8MDMA |
| 9MDMA-d5 |
| 10Methamphetamine |
| 11Methamphetamine-d14 |
| 12Norephedrine |
| 13Norpseudoephedrine |
| 14Phentermine |
| 15Pseudoephedrine |
search
Applications
Expanded Amphetamines and Interferences by MSD on a ZB-Drug-1
17932
Separation Mode: Application Specific
Application Specific
ZB-Drug-1
GC
Adrenergic Agents,Vasoconstrictor Agents,Sympathomimetics,Serotonin Agents,Nasal Decongestants,Hallucinogens,Dopamine Uptake Inhibitors,Dopamine Agents,Adrenergic Uptake Inhibitors,Adrenergic beta-Agonists
Forensics/Toxicology
Toxicology / Drug Screening / TDM
Therapeutic / Clinical
Analytes
Details
GC Conditions (App ID: 17932)
Column: |
Part No: |
Phase Name: ZB-Drug-1 |
Sample Notes: Analytes are 40ppm derivatized with HFBA
Sim ions:
(Quant ion*) D11-Amphetamine (*244,128): Amphetamine (*240,118,117): D14-Methamphetamine (*261,213): Methamphetamine (*254,210,118): D5-MDA (*167,380,244): MDA (*162,375,240): D5-MDMA (*258,213,164): MDMA (*254,210,389): D5-MDEA (*273,241,408): MDEA (*268,240,403)
Note: Amphetamine-d11 does not share ions with coeluting interferences. |
Similar Applications
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.